Implementation of the Future Regulation of Medical Devices in the UK

1. Overview and Core Objectives The Medicines and Healthcare products Regulatory Agency (MHRA) is progressing with the implementation of a future regulatory framework for medical devices in the United Kingdom. The core objective is to create a world-leading regime that prioritizes patient safety, fosters innovation, and ensures the UK remains an attractive market for global manufacturers. This new framework will be introduced through several statutory instruments designed to update and strengthen existing requirements. Source: UK Gov Guidance: Implementation of the future regulation of medical devices

2. Phased Implementation Timeline To minimize disruption to the industry and healthcare system, the MHRA has adopted a phased approach to implementation. Key milestones include:

Post-market surveillance (PMS): New, strengthened requirements for PMS are expected to be the first major component implemented.

Future Core Regulations: The broader set of core regulations, covering areas such as classification and conformity assessment, is planned to come into effect in 2025. Source: UK Gov Guidance: Implementation of the future regulation of medical devices

3. Transitional Arrangements for Existing Devices The government has established transitional arrangements to allow devices that are already on the market to remain there during the shift to the new rules. Generally:

Devices with a valid CE mark or UKCA mark under current rules can continue to be placed on the Great Britain market until their certificates expire or until specific long-stop dates (e.g., 2028 or 2030 depending on the device type).

These arrangements are intended to prevent supply chain gaps and provide legal certainty for manufacturers. Source: UK Gov Guidance: Implementation of the future regulation of medical devices

4. Key Areas of Regulatory Change The future regime will introduce significant updates across several pillars:

Classification Rules: Alignment with international standards, particularly for software as a medical device (SaMD) and implantable devices.

In Vitro Diagnostics (IVDs): Enhanced scrutiny and revised risk classifications for IVDs.

International Recognition: Exploring pathways for devices already approved by trusted international regulators to gain market access in the UK more efficiently. Source: UK Gov Guidance: Implementation of the future regulation of medical devices

5. Ongoing Stakeholder Engagement The MHRA continues to engage with industry, healthcare professionals, and patient groups to refine the secondary legislation and supporting guidance. Manufacturers are encouraged to stay updated with official government announcements to ensure timely compliance with the upcoming changes. Source: UK Gov Guidance: Implementation of the future regulation of medical devices